EnZene Biosciences
|
Year Established:
2006 |
|
|
Website:
enzene.com |
|
|
Headquarters:
Pune, Maharashtra, IN |
|
|
Company Type:
Mid-Sized Business (10-100M TTM Revenue) |
Enzene is an end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA). As a pioneer in next-generation biologics technologies, Enzene is disrupting the existing biologics manufacturing paradigm with its patented EnzeneX™ technology—the first fully-connected continuous manufacturing™ (FCCM™) platform validated for commercial biologics supply.
We partner with innovators and biosimilar developers to deliver accelerated time-to-market, increased production yields, and cost reductions across a broad range of biologic modalities. Committed to pushing the boundaries of biologics manufacturing innovation, Enzene is striving to reduce monoclonal antibody production costs to below $40 per gram by 2025.
For more information on Enzene Biosciences Ltd., a subsidiary of Alkem Laboratories Ltd, please visit www.enzene.com
| Site | Badges | |
|---|---|---|
| Enzene Biosciences Limited Plot No. A 22, A/1/2 Chakan Industrial Area, Phase 2, Khalumbre, Chakan Pune, Maharashtra, 410501 India | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.